Danielle N McLennan

Medicine · Health Sciences

10h-index843citations18works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(6), Botulinum Toxin and Related Neurological Disorders(4), Advancements in Transdermal Drug Delivery(2), Medication Adherence and Compliance(2), Health Sciences Research and Education(2)

Publications18 total

The contributiion of the lymphatics to the systemic availability of subcutaneously administered recombinant proteins
Figshare·2021Open Access
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Proceedings of the National Academy of Sciences·2012· 274 citedOpen Access
Lymphatic Absorption of Subcutaneously Administered Proteins: Influence of Different Injection Sites on the Absorption of Darbepoetin Alfa Using a Sheep Model
Drug Metabolism and Disposition·2007· 67 cited
Lymphatic absorption of subcutaneously administered proteins in sheep: Influence of different injection sites
KU ScholarWorks (The University of Kansas)·2006Open Access
The Absorption of Darbepoetin Alfa Occurs Predominantly via the Lymphatics Following Subcutaneous Administration to Sheep
Pharmaceutical Research·2006· 38 cited
Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep
Journal of Pharmacology and Experimental Therapeutics·2005· 54 cited
Subcutaneous drug delivery and the role of the lymphatics
Drug Discovery Today Technologies·2005· 252 cited
Pharmacokinetic Model to Describe the Lymphatic Absorption of r-metHu-Leptin After Subcutaneous Injection to Sheep
Pharmaceutical Research·2003· 35 cited
Lymphatic Absorption Is a Significant Contributor to the Subcutaneous Bioavailability of Insulin in a Sheep Model
Pharmaceutical Research·2001· 63 cited
Multicentre Pilot Study of a Standard Approach to Document Clinical Pharmacy Activity
The Australian Journal of Hospital Pharmacy·2000· 15 cited
National Survey of Clinical Activity Documentation Practices
The Australian Journal of Hospital Pharmacy·2000· 22 cited
Beneficial clinical outcomes resulting from pharmacist interventions
Journal of Oncology Pharmacy Practice·1999· 15 cited
ICD‐10‐AM Activity Codes: An Opportunity for Standardisation
The Australian Journal of Hospital Pharmacy·1999· 8 cited
Clinical outcomes associated with pharmacist-initiated changes in drug therapy and patient management
1999
Application of ICD-10 activity codes into clinical pharmacy in Australia
1999
Assessing compliance with prescribed doses in palliative care patients
1999
Universal application of ICD-10-AM codes for classification of pharmacist activities
1998
Clinical outcomes associated with interventions by pharmacists in an oncology setting
1998

Frequent Co-authors

Michael Dooley(9), Susan A. Charman(8), Christopher J. H. Porter(7), Jo‐anne E Brien(6), Glenn A. Edwards(5), Steven W. Martin(3), Jagannath Kota(2), Krishna K. Machavaram(2), Anne C. Heatherington(2), Yongyuth Yuthavong(1), Bongkoch Tarnchompoo(1), Tirayut Vilaivan(1), P. Chitnumsub(1), Sumalee Kamchonwongpaisan(1), Karen L. White(1), Livia Vivas(1), Emily Bongard(1), Chawanee Thongphanchang(1), Supannee Taweechai(1), Jarunee Vanichtanankul(1)